TC
Thomas Clozel
About
Thomas Clozel is a French oncologist, entrepreneur, and angel investor, co-founder and CEO of Owkin, a scientific AI company that leverages machine learning to enhance medical research, valued at over $1 billion following Sanofi's investment in 2021. He is the son of Jean-Paul and Martine Clozel, founders of Swiss biotech Actelion. His angel investments span AI, biotech, and climate innovation.
Comments
No comments yet. Be the first to share your take.
Frequently asked
What type of investor is Thomas Clozel?
Thomas Clozel is a French oncologist, entrepreneur, and angel investor, co-founder and CEO of Owkin, a scientific AI company that leverages machine learning to enhance medical research, valued at over $1 billion following Sanofi's investment in 2021. He is the son of Jean-Paul and Martine Clozel, founders of Swiss biotech Actelion. His angel investments span AI, biotech, and climate innovation.
What kind of firm is Thomas Clozel?
Thomas Clozel is a angel.
Where is Thomas Clozel based?
Thomas Clozel is based in France.
What sectors does Thomas Clozel focus on?
Thomas Clozel focuses on AI, Biotech, Healthcare, Climate Tech.